iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://dx.doi.org/10.1038/nrcardio.2016.45
Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis | Nature Reviews Cardiology
Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis

Nature Reviews Cardiology volume 13, pages 321–332 (2016)Cite this article

Subjects

Key Points

  • Women generally have lower age-adjusted incidence and prevalence of atrial fibrillation (AF) than men; however, given the greater longevity of women, the absolute number of men and women with AF is similar

  • The prevalence of major risk factors differ by sex; women have higher prevalence of hypertension and valvular heart disease, and lower prevalence of coronary heart disease, than men

  • Women are more likely to present with atypical symptoms, such as weakness and fatigue, have longer duration of symptoms, and report worse quality of life and more-frequent depression than men

  • Female sex has been shown to be a risk factor for AF-related stroke or thromboembolism, myocardial infarction, and mortality, but has not been associated with incident heart failure or dementia

  • Future research is needed to address the knowledge gaps in sex-specific differences in AF

Abstract

Atrial fibrillation (AF) is the most common sustained arrhythmia in women and men worldwide. During the past century, a range of risk factors has been associated with AF, severe complications from the arrhythmia have been identified, and its prevalence has been increasing steadily. Whereas evidence has accumulated regarding sex-specific differences in coronary heart disease and stroke, the differences between women and men with AF has received less attention. We review the current literature on sex-specific differences in the epidemiology of AF, including incidence, prevalence, risk factors, and genetics, and in the pathophysiology and the clinical presentation and prognosis of patients with this arrhythmia. We highlight current knowledge gaps and areas that warrant future research, which might advance understanding of variation in the risk factors and complications of AF, and ultimately aid more-tailored management of the arrhythmia.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Overview of atrial fibrillation in women compared with in men.
Figure 2: Prevalence of atrial fibrillation in women and men.
Figure 3: Risk factors for atrial fibrillation in women and men.
Figure 4: Potential sex-specific differences in pathophysiological mechanisms of atrial fibrillation (AF).

Similar content being viewed by others

References

  1. Chugh, S. S. et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 129, 837–847 (2014).

    Article  PubMed  Google Scholar 

  2. Friberg, L. et al. Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP). Europace 15, 135–140 (2013).

    Article  PubMed  Google Scholar 

  3. Tedrow, U. B. et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study). J. Am. Coll. Cardiol. 55, 2319–2327 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Benjamin, E. J. et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271, 840–844 (1994).

    Article  CAS  PubMed  Google Scholar 

  5. Schnabel, R. B. et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet 386, 154–162 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Christophersen, I. E. & Ellinor, P. T. Genetics of atrial fibrillation: from families to genomes. J. Hum. Genet. 61, 61–70 (2015).

    Article  PubMed  CAS  Google Scholar 

  7. Chen, Y. C. et al. Heterogeneous expression of potassium currents and pacemaker currents potentially regulates arrhythmogenesis of pulmonary vein cardiomyocytes. J. Cardiovasc. Electrophysiol. 20, 1039–1045 (2009).

    Article  PubMed  Google Scholar 

  8. Oyen, N. et al. Familial aggregation of lone atrial fibrillation in young persons. J. Am. Coll. Cardiol. 60, 917–921 (2012).

    Article  PubMed  Google Scholar 

  9. Zoller, B., Ohlsson, H., Sundquist, J. & Sundquist, K. High familial risk of atrial fibrillation/atrial flutter in multiplex families: a nationwide family study in Sweden. J. Am. Heart Assoc. 2, e003384 (2013).

    Article  PubMed Central  Google Scholar 

  10. Ball, J., Carrington, M. J., Wood, K. A., Stewart, S. & Investigators, S. Women versus men with chronic atrial fibrillation: insights from the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY). PLoS ONE 8, e65795 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Scheuermeyer, F. X. et al. There are sex differences in the demographics and risk profiles of emergency department (ED) patients with atrial fibrillation and flutter, but no apparent differences in ED management or outcomes. Acad. Emerg. Med. 22, 1067–1075 (2015).

    Article  PubMed  Google Scholar 

  12. Xiong, Q., Proietti, M., Senoo, K. & Lip, G. Y. Asymptomatic versus symptomatic atrial fibrillation: a systematic review of age/gender differences and cardiovascular outcomes. Int. J. Cardiol. 191, 172–177 (2015).

    Article  PubMed  Google Scholar 

  13. Humphries, K. H. et al. New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation 103, 2365–2370 (2001).

    Article  CAS  PubMed  Google Scholar 

  14. Bushnell, C. et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45, 1545–1588 (2014).

    Article  PubMed  Google Scholar 

  15. Benjamin, E. J. et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98, 946–952 (1998).

    Article  CAS  PubMed  Google Scholar 

  16. Miyasaka, Y. et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114, 119–125 (2006).

    Article  PubMed  Google Scholar 

  17. Chien, K. L. et al. Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese. Int. J. Cardiol. 139, 173–180 (2010).

    Article  PubMed  Google Scholar 

  18. Wilke, T. et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace 15, 486–493 (2013).

    Article  PubMed  Google Scholar 

  19. Piccini, J. P. et al. Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993–2007. Circ. Cardiovasc. Qual. Outcomes 5, 85–93 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  20. Svennberg, E. et al. Mass screening for untreated atrial fibrillation: the STROKESTOP Study. Circulation 131, 2176–2184 (2015).

    Article  PubMed  Google Scholar 

  21. Li, Y. et al. Prevalence of atrial fibrillation in China and its risk factors. Biomed. Environ. Sci. 26, 709–716 (2013).

    PubMed  Google Scholar 

  22. Zhou, Z. & Hu, D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J. Epidemiol. 18, 209–216 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  23. Yap, K. B., Ng, T. P. & Ong, H. Y. Low prevalence of atrial fibrillation in community-dwelling Chinese aged 55 years or older in Singapore: a population-based study. J. Electrocardiol. 41, 94–98 (2008).

    Article  PubMed  Google Scholar 

  24. Jeong, J. H. Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years. J. Korean Med. Sci. 20, 26–30 (2005).

    Article  PubMed  PubMed Central  Google Scholar 

  25. Inoue, H. et al. Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination. Int. J. Cardiol. 137, 102–107 (2009).

    Article  PubMed  Google Scholar 

  26. Iguchi, Y. et al. Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city. Circ. J. 72, 909–913 (2008).

    Article  PubMed  Google Scholar 

  27. Ohsawa, M. et al. Rapid increase in estimated number of persons with atrial fibrillation in Japan: an analysis from national surveys on cardiovascular diseases in 1980, 1990 and 2000. J. Epidemiol. 15, 194–196 (2005).

    Article  PubMed  PubMed Central  Google Scholar 

  28. Stefansdottir, H., Aspelund, T., Gudnason, V. & Arnar, D. O. Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace 13, 1110–1117 (2011).

    Article  PubMed  Google Scholar 

  29. Majeed, A., Moser, K. & Carroll, K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994–1998: analysis of data from the general practice research database. Heart 86, 284–288 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Lloyd-Jones, D. M. et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110, 1042–1046 (2004).

    Article  PubMed  Google Scholar 

  31. Heeringa, J. et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur. Heart J. 27, 949–953 (2006).

    Article  PubMed  Google Scholar 

  32. Guo, Y. et al. Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation. Chest 147, 109–119 (2015).

    Article  PubMed  Google Scholar 

  33. Alonso, A. et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J. Am. Heart Assoc. 2, e000102 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  34. Wang, T. J. et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 292, 2471–2477 (2004).

    Article  CAS  PubMed  Google Scholar 

  35. Potpara, T. S. et al. Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study. Int. J. Cardiol. 161, 39–44 (2012).

    Article  PubMed  Google Scholar 

  36. Dagres, N. et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J. Am. Coll. Cardiol. 49, 572–577 (2007).

    Article  PubMed  Google Scholar 

  37. Conen, D. et al. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation 119, 2146–2152 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  38. Huxley, R. R. et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 123, 1501–1508 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  39. Chiang, C. E. et al. Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry. Circ. Arrhythm. Electrophysiol. 5, 632–639 (2012).

    Article  PubMed  Google Scholar 

  40. Murin, J. et al. Clinical characteristics, management, and control of permanent versus nonpermanent atrial fibrillation: insights from the RealiseAF survey. PLoS ONE 9, e86443 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  41. Larsson, S. C., Drca, N. & Wolk, A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J. Am. Coll. Cardiol. 64, 281–289 (2014).

    Article  CAS  PubMed  Google Scholar 

  42. Ofman, P. et al. Regular physical activity and risk of atrial fibrillation: a systematic review and meta-analysis. Circ. Arrhythm. Electrophysiol. 6, 252–256 (2013).

    Article  PubMed  Google Scholar 

  43. Selmer, C. et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ 345, e7895 (2012).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Aviles, R. J. et al. Inflammation as a risk factor for atrial fibrillation. Circulation 108, 3006–3010 (2003).

    Article  PubMed  Google Scholar 

  45. Aizer, A. et al. Relation of vigorous exercise to risk of atrial fibrillation. Am. J. Cardiol. 103, 1572–1577 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  46. Myrstad, M. et al. Effect of years of endurance exercise on risk of atrial fibrillation and atrial flutter. Am. J. Cardiol. 114, 1229–1233 (2014).

    Article  PubMed  Google Scholar 

  47. Mozaffarian, D., Furberg, C. D., Psaty, B. M. & Siscovick, D. Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study. Circulation 118, 800–807 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  48. Everett, B. M. et al. Physical activity and the risk of incident atrial fibrillation in women. Circ. Cardiovasc. Qual. Outcomes 4, 321–327 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  49. Azarbal, F. et al. Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women. J. Am. Heart Assoc. 3, e001127 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  50. Drca, N., Wolk, A., Jensen-Urstad, M. & Larsson, S. C. Physical activity is associated with a reduced risk of atrial fibrillation in middle-aged and elderly women. Heart 101, 1627–1630 (2015).

    Article  CAS  PubMed  Google Scholar 

  51. Arnar, D. O. et al. Familial aggregation of atrial fibrillation in Iceland. Eur. Heart J. 27, 708–712 (2006).

    Article  PubMed  Google Scholar 

  52. Chen, L. Y., Herron, K. J., Tai, B. C. & Olson, T. M. Lone atrial fibrillation: influence of familial disease on gender predilection. J. Cardiovasc. Electrophysiol. 19, 802–806 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  53. Christophersen, I. E. et al. Familial aggregation of atrial fibrillation: a study in Danish twins. Circ. Arrhythm. Electrophysiol. 2, 378–383 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  54. Ellinor, P. T., Yoerger, D. M., Ruskin, J. N. & MacRae, C. A. Familial aggregation in lone atrial fibrillation. Hum. Genet. 118, 179–184 (2005).

    Article  PubMed  Google Scholar 

  55. Fox, C. S. et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 291, 2851–2855 (2004).

    Article  CAS  PubMed  Google Scholar 

  56. Yang, Y. Q. et al. Familial aggregation of lone atrial fibrillation in the Chinese population. Intern. Med. 49, 2385–2391 (2010).

    Article  PubMed  Google Scholar 

  57. Lubitz, S. A. et al. Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. JAMA 304, 2263–2269 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Ravn, L. S. et al. Relation of 97T polymorphism in KCNE5 to risk of atrial fibrillation. Am. J. Cardiol. 96, 405–407 (2005).

    Article  CAS  PubMed  Google Scholar 

  59. Karst, M. L., Herron, K. J. & Olson, T. M. X-linked nonsyndromic sinus node dysfunction and atrial fibrillation caused by emerin mutation. J. Cardiovasc. Electrophysiol. 19, 510–515 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  60. January, C. T. et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 130, e199–e267 (2014).

    PubMed  PubMed Central  Google Scholar 

  61. Haissaguerre, M. et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 339, 659–666 (1998).

    Article  CAS  PubMed  Google Scholar 

  62. Hocini, M. et al. Electrical conduction in canine pulmonary veins: electrophysiological and anatomic correlation. Circulation 105, 2442–2448 (2002).

    Article  PubMed  Google Scholar 

  63. Kamalvand, K. et al. Alterations in atrial electrophysiology associated with chronic atrial fibrillation in man. Eur. Heart J. 20, 888–895 (1999).

    Article  CAS  PubMed  Google Scholar 

  64. Raitt, M. H., Kusumoto, W., Giraud, G. & McAnulty, J. H. Reversal of electrical remodeling after cardioversion of persistent atrial fibrillation. J. Cardiovasc. Electrophysiol. 15, 507–512 (2004).

    Article  PubMed  Google Scholar 

  65. Franz, M. R., Karasik, P. L., Li, C., Moubarak, J. & Chavez, M. Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. J. Am. Coll. Cardiol. 30, 1785–1792 (1997).

    Article  CAS  PubMed  Google Scholar 

  66. Wijffels, M. C., Kirchhof, C. J., Dorland, R. & Allessie, M. A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92, 1954–1968 (1995).

    Article  CAS  PubMed  Google Scholar 

  67. Ehrlich, J. R. et al. Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties. J. Physiol. 551, 801–813 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Platonov, P. G., Mitrofanova, L. B., Orshanskaya, V. & Ho, S. Y. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J. Am. Coll. Cardiol. 58, 2225–2232 (2011).

    Article  PubMed  Google Scholar 

  69. Henry, W. L. et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 53, 273–279 (1976).

    Article  CAS  PubMed  Google Scholar 

  70. Vasan, R. S., Larson, M. G., Levy, D., Evans, J. C. & Benjamin, E. J. Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation. Circulation 96, 1863–1873 (1997).

    Article  CAS  PubMed  Google Scholar 

  71. Vaziri, S. M., Larson, M. G., Benjamin, E. J. & Levy, D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 89, 724–730 (1994).

    Article  CAS  PubMed  Google Scholar 

  72. Nattel, S., Burstein, B. & Dobrev, D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ. Arrhythm. Electrophysiol. 1, 62–73 (2008).

    Article  PubMed  Google Scholar 

  73. Anne, W. et al. Self-terminating AF depends on electrical remodeling while persistent AF depends on additional structural changes in a rapid atrially paced sheep model. J. Mol. Cell. Cardiol. 43, 148–158 (2007).

    Article  CAS  PubMed  Google Scholar 

  74. Filgueiras-Rama, D. et al. Long-term frequency gradients during persistent atrial fibrillation in sheep are associated with stable sources in the left atrium. Circ. Arrhythm. Electrophysiol. 5, 1160–1167 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  75. Remes, J. et al. Persistent atrial fibrillation in a goat model of chronic left atrial overload. J. Thorac. Cardiovasc. Surg. 136, 1005–1011 (2008).

    Article  PubMed  Google Scholar 

  76. Ravens, U. Antiarrhythmic therapy in atrial fibrillation. Pharmacol. Ther. 128, 129–145 (2010).

    Article  CAS  PubMed  Google Scholar 

  77. Sanfilippo, A. J. et al. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation 82, 792–797 (1990).

    Article  CAS  PubMed  Google Scholar 

  78. Kishi, S. et al. Race-ethnic and sex differences in left ventricular structure and function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. J. Am. Heart Assoc. 4, e001264 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  79. Tsang, T. S. et al. Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin. Proc. 76, 467–475 (2001).

    Article  CAS  PubMed  Google Scholar 

  80. Hudsmith, L. E., Petersen, S. E., Francis, J. M., Robson, M. D. & Neubauer, S. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J. Cardiovasc. Magn. Reson. 7, 775–782 (2005).

    Article  PubMed  Google Scholar 

  81. McManus, D. D. et al. Longitudinal tracking of left atrial diameter over the adult life course: clinical correlates in the community. Circulation 121, 667–674 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  82. Cochet, H. et al. Age, atrial fibrillation, and structural heart disease are the main determinants of left atrial fibrosis detected by delayed-enhanced magnetic resonance imaging in a general cardiology population. J. Cardiovasc. Electrophysiol. 26, 484–492 (2015).

    Article  PubMed  Google Scholar 

  83. Khera, A. et al. Race and gender differences in C-reactive protein levels. J. Am. Coll. Cardiol. 46, 464–469 (2005).

    Article  CAS  PubMed  Google Scholar 

  84. Mathew, J. S. et al. Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS). Circulation 130, 298–307 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Patel, P., Dokainish, H., Tsai, P. & Lakkis, N. Update on the association of inflammation and atrial fibrillation. J. Cardiovasc. Electrophysiol. 21, 1064–1070 (2010).

    Article  PubMed  Google Scholar 

  86. Panwar, B. et al. Fibroblast growth factor 23 and risk of incident stroke in community-living adults. Stroke 46, 322–328 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Tsai, W. C., Chen, Y. C., Lin, Y. K., Chen, S. A. & Chen, Y. J. Sex differences in the electrophysiological characteristics of pulmonary veins and left atrium and their clinical implication in atrial fibrillation. Circ. Arrhythm. Electrophysiol. 4, 550–559 (2011).

    Article  CAS  PubMed  Google Scholar 

  88. Takigawa, M. et al. Differences in catheter ablation of paroxysmal atrial fibrillation between males and females. Int. J. Cardiol. 168, 1984–1991 (2013).

    Article  PubMed  Google Scholar 

  89. Yang, P. C., Kurokawa, J., Furukawa, T. & Clancy, C. E. Acute effects of sex steroid hormones on susceptibility to cardiac arrhythmias: a simulation study. PLoS Comput. Biol. 6, e1000658 (2010).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  90. Nakamura, H. et al. Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study. Circulation 116, 2913–2922 (2007).

    Article  CAS  PubMed  Google Scholar 

  91. Nakagawa, M. et al. Influence of menstrual cycle on QT interval dynamics. Pacing Clin. Electrophysiol. 29, 607–613 (2006).

    Article  PubMed  Google Scholar 

  92. Rosano, G. M. et al. Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet 347, 786–788 (1996).

    Article  CAS  PubMed  Google Scholar 

  93. Rosano, G. M. et al. Acute electrophysiologic effect of estradiol 17β in menopausal women. Am. J. Cardiol. 86, 1385–1387 (2000).

    Article  CAS  PubMed  Google Scholar 

  94. Saba, S. et al. Effects of estrogen on cardiac electrophysiology in female mice. J. Cardiovasc. Electrophysiol. 13, 276–280 (2002).

    Article  PubMed  Google Scholar 

  95. Perez, M. V. et al. Effects of postmenopausal hormone therapy on incident atrial fibrillation: the Women's Health Initiative randomized controlled trials. Circ. Arrhythm. Electrophysiol. 5, 1108–1116 (2012).

    Article  CAS  PubMed  Google Scholar 

  96. Drici, M. D., Burklow, T. R., Haridasse, V., Glazer, R. I. & Woosley, R. L. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation 94, 1471–1474 (1996).

    Article  CAS  PubMed  Google Scholar 

  97. Liu, X. K. et al. Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J. Pharmacol. Exp. Ther. 285, 672–679 (1998).

    CAS  PubMed  Google Scholar 

  98. Stramba-Badiale, M., Locati, E. H., Martinelli, A., Courville, J. & Schwartz, P. J. Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-h Holter recordings. Eur. Heart J. 18, 1000–1006 (1997).

    Article  CAS  PubMed  Google Scholar 

  99. Nielsen, J. B. et al. Risk of atrial fibrillation as a function of the electrocardiographic PR interval: results from the Copenhagen ECG Study. Heart Rhythm 10, 1249–1256 (2013).

    Article  PubMed  Google Scholar 

  100. Cheng, S. et al. Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA 301, 2571–2577 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Buitrago, C., Massheimer, V. & de Boland, A. R. Acute modulation of Ca2+ influx on rat heart by 17β-estradiol. Cell. Signal. 12, 47–52 (2000).

    Article  CAS  PubMed  Google Scholar 

  102. Jovanovic, S., Jovanovic, A., Shen, W. K. & Terzic, A. Low concentrations of 17β-estradiol protect single cardiac cells against metabolic stress-induced Ca2+ loading. J. Am. Coll. Cardiol. 36, 948–952 (2000).

    Article  CAS  PubMed  Google Scholar 

  103. Magnani, J. W. et al. Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study. Circ. Arrhythm. Electrophysiol. 7, 307–312 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  104. Tsuneda, T. et al. Deficiency of testosterone associates with the substrate of atrial fibrillation in the rat model. J. Cardiovasc. Electrophysiol. 20, 1055–1060 (2009).

    Article  PubMed  Google Scholar 

  105. Cove, C. L. et al. Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms. Thromb. Haemost. 111, 385–391 (2014).

    Article  CAS  PubMed  Google Scholar 

  106. Soliman, E. Z. et al. Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 131, 1843–1850 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  107. Udelson, J. E. Heart failure with preserved ejection fraction. Circulation 124, e540–e543 (2011).

    PubMed  Google Scholar 

  108. Clayton, J. A. & Collins, F. S. Policy: NIH to balance sex in cell and animal studies. Nature 509, 282–283 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  109. Lip, G. Y. et al. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry). Eur. Heart J. 35, 3365–3376 (2014).

    Article  CAS  PubMed  Google Scholar 

  110. Paquette, M. et al. Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. Am. J. Cardiol. 86, 764–768 (2000).

    Article  CAS  PubMed  Google Scholar 

  111. Sanna, T. et al. Cryptogenic stroke and underlying atrial fibrillation. N. Engl. J. Med. 370, 2478–2486 (2014).

    Article  CAS  PubMed  Google Scholar 

  112. Bekwelem, W. et al. Extracranial systemic embolic events in patients with nonvalvular atrial fibrillation: incidence, risk factors, and outcomes. Circulation 132, 796–803 (2015).

    Article  PubMed  Google Scholar 

  113. Frost, L. et al. Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation. Arch. Intern. Med. 161, 272–276 (2001).

    Article  CAS  PubMed  Google Scholar 

  114. Andersen, L. V. et al. Atrial fibrillation and upper limb thromboembolectomy: a national cohort study. J. Thromb. Haemost. 9, 1738–1743 (2011).

    Article  CAS  PubMed  Google Scholar 

  115. Camm, A. J. et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. Eur. Heart J. 33, 2719–2747 (2012).

    Article  PubMed  Google Scholar 

  116. Wang, T. J. et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA 290, 1049–1056 (2003).

    Article  PubMed  Google Scholar 

  117. Mikkelsen, A. P. et al. Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study. J. Thromb. Haemost. 10, 1745–1751 (2012).

    Article  CAS  PubMed  Google Scholar 

  118. Friberg, L., Benson, L., Rosenqvist, M. & Lip, G. Y. Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study. BMJ 344, e3522 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  119. Fang, M. C. et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation 112, 1687–1691 (2005).

    Article  PubMed  PubMed Central  Google Scholar 

  120. Friberg, J., Scharling, H., Gadsboll, N., Truelsen, T. & Jensen, G. B. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am. J. Cardiol. 94, 889–894 (2004).

    Article  PubMed  Google Scholar 

  121. Inoue, H. & Atarashi, H. Risk factors for thromboembolism in patients with paroxysmal atrial fibrillation. Am. J. Cardiol. 86, 852–855 (2000).

    Article  CAS  PubMed  Google Scholar 

  122. Avgil Tsadok, M. et al. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. JAMA 307, 1952–1958 (2012).

    Article  PubMed  Google Scholar 

  123. Aronow, W. S., Ahn, C., Kronzon, I. & Gutstein, H. Risk factors for new thromboembolic stroke in patients ≥62 years of age with chronic atrial fibrillation. Am. J. Cardiol. 82, 119–121 (1998).

    Article  CAS  PubMed  Google Scholar 

  124. Stollberger, C. et al. Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. Ann. Intern. Med. 128, 630–638 (1998).

    Article  CAS  PubMed  Google Scholar 

  125. Van Staa, T. P., Setakis, E., Di Tanna, G. L., Lane, D. A. & Lip, G. Y. A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice. J. Thromb. Haemost. 9, 39–48 (2011).

    Article  CAS  PubMed  Google Scholar 

  126. Olesen, J. B., Fauchier, L., Lane, D. A., Taillandier, S. & Lip, G. Y. Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. Chest 141, 147–153 (2012).

    Article  PubMed  Google Scholar 

  127. Poli, D., Antonucci, E., Testa, S., Ageno, W. & Palareti, G. Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics). Thromb. Res. 131, 12–16 (2013).

    Article  CAS  PubMed  Google Scholar 

  128. Overvad, T. F. et al. Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation. Thromb. Haemost. 112, 789–795 (2014).

    Article  PubMed  Google Scholar 

  129. Cha, M.-J., Oh, G.-C., Hahn, S., Choi, E.-K. & Oh, S. Thromboembolic risk evaluation in patients with atrial fibrillation using a modified CHADS2 scoring system. J. Cardiovasc. Electrophysiol. 23, 155–162 (2012).

    Article  PubMed  Google Scholar 

  130. Nakagami, H. et al. Mitral regurgitation reduces the risk of stroke in patients with nonrheumatic atrial fibrillation. Am. Heart J. 136, 528–532 (1998).

    Article  CAS  PubMed  Google Scholar 

  131. Inoue, H. et al. Impact of gender on the prognosis of patients with nonvalvular atrial fibrillation. Am. J. Cardiol. 113, 957–962 (2014).

    Article  PubMed  Google Scholar 

  132. Siu, C.-W., Lip, G. Y. H., Lam, K.-F. & Tse, H.-F. Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong. Heart Rhythm 11, 1401–1408 (2014).

    Article  PubMed  Google Scholar 

  133. Friberg, L., Skeppholm, M. & Terént, A. Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1. J. Am. Coll. Cardiol. 65, 225–232 (2015).

    Article  PubMed  Google Scholar 

  134. Olesen, J. B. et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 342, d124 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  135. de Bruijn, R. F. et al. Association between atrial fibrillation and dementia in the general population. JAMA Neurol. 72, 1288–1294 (2015).

    Article  PubMed  Google Scholar 

  136. Miyasaka, Y. et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort. Eur. Heart J. 28, 1962–1967 (2007).

    Article  PubMed  Google Scholar 

  137. Liao, J. N. et al. Risk and prediction of dementia in patients with atrial fibrillation — a nationwide population-based cohort study. Int. J. Cardiol. 199, 25–30 (2015).

    Article  PubMed  Google Scholar 

  138. Horstmann, S. et al. Atrial fibrillation and prestroke cognitive impairment in stroke. J. Neurol. 261, 546–553 (2014).

    Article  CAS  PubMed  Google Scholar 

  139. Bunch, T. J. et al. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Heart Rhythm 7, 433–437 (2010).

    Article  PubMed  Google Scholar 

  140. Dublin, S. et al. Atrial fibrillation and risk of dementia: a prospective cohort study. J. Am. Geriatr. Soc. 59, 1369–1375 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  141. Forti, P. et al. Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment (MCI). Arch. Gerontol. Geriatr. 44 (Suppl. 1), 155–165 (2007).

    Article  PubMed  Google Scholar 

  142. Rusanen, M. et al. Heart diseases and long-term risk of dementia and Alzheimer's disease: a population-based CAIDE study. J. Alzheimers Dis. 42, 183–191 (2014).

    Article  PubMed  Google Scholar 

  143. Wang, T. J. et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107, 2920–2925 (2003).

    Article  PubMed  Google Scholar 

  144. Miyasaka, Y. et al. Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades. Eur. Heart J. 27, 936–941 (2006).

    Article  PubMed  Google Scholar 

  145. Schnabel, R. B. et al. Risk assessment for incident heart failure in individuals with atrial fibrillation. Eur. J. Heart Fail. 15, 843–849 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  146. Meyer, S. et al. Sex differences in new-onset heart failure. Clin. Res. Cardiol. 104, 342–350 (2015).

    Article  PubMed  Google Scholar 

  147. Stewart, S., Hart, C. L., Hole, D. J. & McMurray, J. J. V. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am. J. Med. 113, 359–364 (2002).

    Article  PubMed  Google Scholar 

  148. Fukuda, T. et al. Development of congestive heart failure in Japanese patients with atrial fibrillation. Circ. J. 71, 308–312 (2007).

    Article  PubMed  Google Scholar 

  149. Goyal, A. et al. Predictors of incident heart failure in a large insured population: a one million person-year follow-up study. Circ. Heart Fail. 3, 698–705 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  150. Andersson, T. et al. Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: a nationwide cohort study of 9519 patients. Int. J. Cardiol. 177, 91–99 (2014).

    Article  PubMed  Google Scholar 

  151. Potpara, T. S. et al. A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study. Chest 141, 339–347 (2012).

    Article  PubMed  Google Scholar 

  152. Soliman, E. Z. et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern. Med. 174, 107–114 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  153. O'Neal, W. T., Sangal, K., Zhang, Z. M. & Soliman, E. Z. Atrial fibrillation and incident myocardial infarction in the elderly. Clin. Cardiol. 37, 750–755 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  154. Chao, T. F. et al. Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study. Heart Rhythm 11, 1941–1947 (2014).

    Article  PubMed  Google Scholar 

  155. Miyasaka, Y. et al. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J. Am. Coll. Cardiol. 49, 986–992 (2007).

    Article  PubMed  Google Scholar 

  156. Chen, L. Y. et al. Atrial fibrillation and the risk of sudden cardiac death: the Atherosclerosis Risk In Communities study and Cardiovascular Health Study. JAMA Intern. Med. 173, 29–35 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  157. Conen, D. et al. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA 305, 2080–2087 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  158. Stollberger, C., Winkler-Dworak, M., Finsterer, J., Hartl, E. & Chnupa, P. Factors influencing mortality in atrial fibrillation. Post hoc analysis of an observational study in outpatients. Int. J. Cardiol. 103, 140–144 (2005).

    Article  PubMed  Google Scholar 

  159. Marijon, E. et al. Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study. Circulation 128, 2192–2201 (2013).

    Article  CAS  PubMed  Google Scholar 

  160. Olsson, L. G., Swedberg, K., Lappas, G., Stewart, S. & Rosengren, A. Trends in mortality after first hospitalization with atrial fibrillation diagnosis in Sweden 1987 to 2006. Int. J. Cardiol. 170, 75–80 (2013).

    Article  CAS  PubMed  Google Scholar 

  161. Stollberger, C. et al. Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the embolism in left atrial thrombi (ELAT) study. Clin. Cardiol. 27, 40–46 (2004).

    Article  PubMed  Google Scholar 

  162. Nieuwlaat, R. et al. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur. Heart J. 29, 1181–1189 (2008).

    Article  PubMed  Google Scholar 

  163. Gallego, P. et al. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation. Thromb. Haemost. 110, 1189–1198 (2013).

    Article  CAS  PubMed  Google Scholar 

  164. Banerjee, A. et al. Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project. Int. J. Cardiol. 167, 2682–2687 (2013).

    Article  PubMed  Google Scholar 

  165. Zubaid, M. et al. Management and 1-year outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events. Angiology 66, 464–471 (2015).

    Article  PubMed  Google Scholar 

  166. Badheka, A. O. et al. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am. J. Med. 123, 646–651 (2010).

    Article  PubMed  Google Scholar 

  167. Emdin, C. A. et al. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. BMJ 532, h7013 (2016).

    Article  PubMed  CAS  Google Scholar 

  168. Mosca, L., Barrett-Connor, E. & Kass Wenger, N. Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation 124, 2145–2154 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  169. Rahman, F., Kwan, G. F. & Benjamin, E. J. Global epidemiology of atrial fibrillation. Nat. Rev. Cardiol. 11, 639–654 (2014).

    Article  PubMed  Google Scholar 

  170. Nattel, S. New ideas about atrial fibrillation 50 years on. Nature 415, 219–226 (2002).

    Article  CAS  PubMed  Google Scholar 

  171. Gowd, B. M. & Thompson, P. D. Effect of female sex on cardiac arrhythmias. Cardiol. Rev. 20, 297–303 (2012).

    Article  PubMed  Google Scholar 

  172. Apostolakis, S., Sullivan, R. M., Olshansky, B. & Lip, G. Y. Hormone replacement therapy and adverse outcomes in women with atrial fibrillation: an analysis from the atrial fibrillation follow-up investigation of rhythm management trial. Stroke 45, 3076–3079 (2014).

    Article  CAS  PubMed  Google Scholar 

  173. Schnabel, R. B. et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 373, 739–745 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  174. Schnabel, R. B. et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation 121, 200–207 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

D.K. is supported by the National Heart, Lung, and Blood Institute award 5T32HL007224-38 and the National Institutes of Health Clinical and Translational Science Award programme award UL1-TR000157. R.B.S. is supported by European Research Council under the European Union's Horizon 2020 research and innovation programme (agreement No 648131), and Junior Research Alliance symAtrial project funded by the German Ministry of Research and Education (BMBF 01ZX1408A) e:Med – Systems Medicine programme and by Deutsche Forschungsgemeinschaft (German Research Foundation) Emmy Noether Program SCHN 1149/3-1. E.J.B. is supported in part through NIH/NHLBI HHSN268201500001I; N01-HC25195, 2R01HL092577, 1R01 HL102214, 1R01HL128914, and 1RC1HL101056. I.E.C. is supported by a mobility grant from the Research Council of Norway (240149/F20).

Author information

Author notes

  1. Darae Ko and Faisal Rahman: These authors contributed equally to this work.

Authors and Affiliations

  1. Section of General Internal Medicine, Boston Medical Center, Boston University School of Medicine,

    Darae Ko

  2. Department of Internal Medicine, Boston Medical Center, Boston University School of Medicine,

    Faisal Rahman

  3. Department of General and Interventional Cardiology, University Heart Center Hamburg, Martinistrasse 52, Hamburg, 20246, Germany

    Renate B. Schnabel

  4. DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Oudenarder Strasse 16, Berlin, 13347, Germany

    Renate B. Schnabel

  5. Boston University and National Heart, Lung, and Blood Institute's Framingham Heart Study, 73 Mount Wayte Avenue Framingham, 01702, Massachusetts, USA

    Xiaoyan Yin & Emelia J. Benjamin

  6. Department of Biostatistics, Boston University School of Public Health,

    Xiaoyan Yin

  7. Sections of Cardiovascular Medicine and Preventive Medicine, Boston Medical Center, Boston University School of Medicine, 72 East Concord Street, Boston, 02118, Massachusetts, USA

    Emelia J. Benjamin

  8. Department of Epidemiology, Boston University School of Public Health, 715 Albany Street, Boston, 02118, Massachusetts, USA

    Emelia J. Benjamin

  9. Cardiovascular Research Center, Massachusetts General Hospital, 149 13th Street, Charlestown, 02129, Massachusetts, USA

    Ingrid E. Christophersen

  10. Department of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, Sogneprest Munthe-kaas vei 100, Gjettum, 1346, Norway

    Ingrid E. Christophersen

Authors
  1. Darae Ko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Faisal Rahman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Renate B. Schnabel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiaoyan Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Emelia J. Benjamin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ingrid E. Christophersen
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

D.K., F.R., E.J.B., and I.E.C. researched data for the article, discussed its content, and wrote, reviewed and edited the manuscript before submission. X.Y. researched data for the article. R.B.S. discussed the content of the article, and wrote, reviewed, and edited the manuscript before submission.

Corresponding author

Correspondence to Ingrid E. Christophersen.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary information S1 (table)

Incidence of AF in women and men, age-pooled (PDF 71 kb)

Supplementary information S2 (table)

Incidence of AF in women and men, age-specific (PDF 117 kb)

Supplementary information S3 (table)

Prevalence of AF in women and men, age-pooled (PDF 82 kb)

Supplementary information S4 (table)

Prevalence of AF in women and men, age-specific (PDF 204 kb)

Supplementary information S5 (table)

Genetics (PDF 82 kb)

Supplementary information S6 (table)

Stroke and thromboembolism (PDF 188 kb)

Supplementary information S7 (table)

Dementia (PDF 58 kb)

Supplementary information S8 (table)

Heart failure (PDF 85 kb)

Supplementary information S9 (table)

Myocardial infarction (PDF 67 kb)

Supplementary information S10 (table)

Mortality (PDF 119 kb)

Supplementary information S11 (table)

Search strategies (PDF 76 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ko, D., Rahman, F., Schnabel, R. et al. Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nat Rev Cardiol 13, 321–332 (2016). https://doi.org/10.1038/nrcardio.2016.45

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2016.45

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing